# EDGAR Filing Document

**Accession Number:** 0001843586
**File Stem:** 0001193125-25-254614
**Filing Date:** 2025-10
**Character Count:** 50333
**Document Hash:** fd37af88a42d4280589cef44c43507ac
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-254614.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0001193125-25-254614

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20251029

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Oatly Group AB
- **CENTRAL INDEX KEY:** 0001843586
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** V7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40401
- **FILM NUMBER:** 251426781

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** C/O OATLY GROUP
- **STREET 2:** ANGFARJEKAJEN 8
- **CITY:** MALMO
- **PROVINCE COUNTRY:** V7
- **BUSINESS PHONE:** 46 418 47 5500

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** C/O OATLY GROUP
- **STREET 2:** ANGFARJEKAJEN 8
- **CITY:** MALMO
- **PROVINCE COUNTRY:** V7

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Havre Global AB
- **DATE OF NAME CHANGE:** 20210201

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

------

**FORM 6-K**

------

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of October 2025**

**Commission File Number: 001-40401**

------

**Oatly Group AB**

**(Translation of registrant's name into English)**

------

**Ångfärjekajen 8**

**211 19 Malmö**

**Sweden**

**(Address of principal executive office)**

------

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

------

## Results of Operations and Financial Condition
On October 29, 2025, the Company issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Report on Form 6-K.

------

**EXHIBIT INDEX**

---

| | |
|:---|:---|
| Exhibit No.  | Description |
| 99.1 | [<u>Press Release of Oatly Group AB, dated October 29, 2025</u>](otly-ex99_1.htm) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Oatly Group AB** | **Oatly Group AB** |
| Date: October 29, 2025 | By: | /s/ Marie-José David |
|  | Name: | Marie-José David |
|  | Title: | Chief Financial Officer |

---

------

## Exhibit 99.1

**Exhibit 99.1**

![img191691763_0.jpg](img191691763_0.jpg)

**Oatly Reports Third Quarter 2025 Financial Results**

MALMÖ, Sweden, October 29, 2025 – Oatly Group AB (Nasdaq: OTLY) ("Oatly", the "Company" or the "Group"), the world's original and largest oat drink company, today announced financial results for the third quarter ended September 30, 2025.

Jean-Christophe Flatin, Oatly's CEO, commented, "I am proud to report that we drove profitable growth in the quarter, with solid constant currency revenue growth and positive adjusted EBITDA. Achieving this milestone reflects the disciplined, strategic actions we have taken over the past three years to strengthen the foundation of our entire business. While we are proud of this achievement, we know that profitable growth is a milestone and not the finish line. We see significant potential ahead of us, and we are confident that we are taking the right steps to drive durable, scalable, and profitable growth as we execute on our mission."

The tables below reconcile revenue as reported to revenue on a constant currency basis by segment for the three and nine months ended September 30, 2025.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three months ended September 30,** | **Three months ended September 30,** | **$ Change** | **$ Change** | **$ Change** | **% Change** | **% Change** |  |  |
| **<br>(in thousands of U.S. dollars)** | **2025** | **2024** | **As reported** | **Foreign exchange impact** | **In constant currency** | **As reported** | **In constant currency** | **Volume** | **Constant currency price/mix** |
| Europe & International | 123267 | 109853 | 123267 | 6814 | 116453 | 12.2% | 6.0% | 8.4% | -2.4% |
| North America | 62096 | 69073 | 62096 |  | 62096 | -10.1% | -10.1% | -12.8% | 2.7% |
| Greater China | 37433 | 29074 | 37433 | 15 | 37418 | 28.8% | 28.7% | 32.2% | -3.5% |
| **Total revenue** | **222796** | **208000** | **222796** | **6829** | **215967** | **7.1%** | **3.8%** | **6.6%** | **-2.8%** |
| **(Unaudited)** | **Nine months ended September 30,** | **Nine months ended September 30,** | **$ Change** | **$ Change** | **$ Change** | **% Change** | **% Change** |  |  |
| **<br>(in thousands of U.S. dollars)** | **2025** | **2024** | **As reported** | **Foreign exchange impact** | **In constant currency** | **As reported** | **In constant currency** | **Volume** | **Constant currency price/mix** |
| Europe & International | 349125 | 325801 | 349125 | 10920 | 338205 | 7.2% | 3.8% | 7.2% | -3.4% |
| North America | 185167 | 203859 | 185167 |  | 185167 | -9.2% | -9.2% | -10.4% | 1.2% |
| Greater China | 94388 | 79690 | 94388 | (202) | 94590 | 18.4% | 18.7% | 32.4% | -13.7% |
| **Total revenue** | **628680** | **609350** | **628680** | **10718** | **617962** | **3.2%** | **1.4%** | **6.2%** | **-4.8%** |

---

**Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Third quarter revenue of $222.8 million, a 7.1% increase compared to the prior year period, with a constant currency revenue increase of 3.8% compared to the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Gross margin in the third quarter was 29.8%, which was flat compared to the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Third quarter net loss attributable to shareholders of the parent was $65.3 million, which is an increase of $30.7 million compared to a net loss attributable to shareholders of the parent of $34.6 million in the prior year period primarily due to fair value losses on Convertible Notes.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Third quarter Adjusted EBITDA was $3.1 million, which is an improvement of $8.2 million compared to the prior year period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The Company is reaffirming its 2025 outlook on its primary guidance metrics as follows:

oConstant currency revenue growth is expected to be in the range of approximately flat to +1%;

oAdjusted EBITDA is expected to be in the range of positive $5 million to $15 million;

oCapital expenditures are expected to be approximately $20 million.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•The Company's strategic review of its Greater China business is ongoing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Subsequent to quarter-end, on October 3, 2025, the Company completed its previously-announced refinancing by using proceeds from issuance of Nordic Bonds to prepay the Term Loan B Credit Agreement in full, repurchase and cancel certain of its U.S. Convertible Notes and by canceling, terminating, and replacing its existing revolving credit facility with a new super senior revolving credit facility.

**Third Quarter 2025 Results**

Revenue increased $14.8 million, or 7.1% to $222.8 million for the third quarter ended September 30, 2025, compared to $208.0 million for the prior year period. Excluding a foreign currency exchange tailwind of $6.8 million, revenue for the third quarter was $216.0 million, or an increase of 3.8% compared to the prior year period. The growth in constant currency revenue was primarily driven by another quarter of consistent performance in Europe & International and by a strong quarter in Greater China, partially offset by decline in North America, driven mainly by reduction in revenue to the segment's largest foodservice customer. Sold volume for the third quarter of 2025 increased 6.6% to 150.6 million liters compared to 141.3 million liters in the third quarter of 2024. Produced finished goods volume for the third quarter of 2025 was 147.6 million liters compared to 148.0 million liters for the third quarter of 2024.

Gross profit was $66.3 million for the third quarter of 2025 compared to $62.0 million for the third quarter of 2024. Gross profit margin was 29.8% in the third quarter of 2025, which was flat compared to the prior year period. The margin stability compared to the third quarter of 2024 was explained by improvements in supply chain efficiency in Europe & International and the benefits of foreign exchange, offset by declines due to lower volumes in North America, negative mix impact in Greater China, and inflation.

Research and development expenses in the third quarter of 2025 decreased $6.3 million to $4.5 million compared to $10.9 million in the prior year period. The decrease was mainly explained by expenses in the prior year period related to a new product launch issue in the North America segment.

Selling, general and administrative expenses in the third quarter of 2025 decreased $4.6 million to $75.1 million compared to $79.7 million in the prior year period. The Company continued to take actions to reduce overhead expenses, which was partially offset by foreign exchange movements and increased customer distribution expenses related to increased sold volume.

Other operating income and (expenses), net for the third quarter of 2025 was an expense of $3.6 million comprised primarily of $3.5 million in costs for the Company's strategic review of the Greater China segment. Other operating income and (expenses), net for the prior year period was an expense of $0.4 million.

Finance income and (expenses), net for the third quarter of 2025 was an expense of $47.6 million comprised primarily of fair value losses on Convertible Notes of $32.2 million and net interest expenses of $15.2 million. The finance income and (expenses), net for the prior year period was an expense of $4.3 million comprised primarily of net interest expenses of $13.3 million, offset by fair value gains on Convertible Notes of $5.3 million and net foreign exchange gains of $4.5 million.

Net loss attributable to shareholders of the parent was $65.3 million for the third quarter of 2025 compared to a loss of $34.6 million in the prior year period. The increase in loss was primarily due to fair value losses on Convertible Notes, partially offset by higher gross profit, lower research and development and selling, general and administrative expenses.

Adjusted EBITDA for the third quarter of 2025 was $3.1 million, compared to a loss of $5.0 million in the prior year period. The improvement in Adjusted EBITDA was primarily a result of higher gross profit, lower research and development and selling, general and administrative expenses.

*EBITDA, Adjusted EBITDA loss, and Constant Currency Revenue are non-IFRS financial measures defined under "Non-IFRS financial measures". Please see above revenue at constant currency table and "Reconciliation of IFRS to Non-IFRS Financial measures" at the end of this press release.*

The following tables set forth revenue, Adjusted EBITDA, EBITDA and loss before tax for the Company's three reportable segments for the periods presented.

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Revenue, Adjusted EBITDA and EBITDA** |  |  |  |  |  |  |
| **Three months ended September 30, 2025<br>(Unaudited)<br>(in thousands of U.S. dollars)** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 123267 | 62096 | 37433 |  |  | 222796 |
| Intersegment revenue | 130 |  |  |  | (130) |  |
| **Total segment revenue** | **123397** | **62096** | **37433** | **—** | **(130)** | **222796** |
| **Adjusted EBITDA** | **21876** | **(1270)** | **1586** | **(19076)** | **—** | **3116** |
| Share-based compensation expense | (504) | (318) | (494) | (1764) |  | (3080) |
| Restructuring costs<sup>(1)</sup> | (239) | (298) |  | (513) |  | (1050) |
| Strategic review of Greater China business<sup>(2)</sup> |  |  | (3533) |  |  | (3533) |
| Non-controlling interests |  |  | (117) |  |  | (117) |
| **EBITDA** | **21133** | **(1886)** | **(2558)** | **(21353)** | **—** | **(4664)** |
| Finance income and (expenses), net |  |  |  |  |  | (47557) |
| Depreciation and amortization |  |  |  |  |  | (12260) |
| **Loss before tax** | **—** | **—** | **—** | **—** | **—** | **(64481)** |
| **Three months ended September 30, 2024<br>(Unaudited)<br>(in thousands of U.S. dollars)** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 109853 | 69073 | 29074 |  |  | 208000 |
| Intersegment revenue | 1325 |  |  |  | (1325) |  |
| **Total segment revenue** | **111178** | **69073** | **29074** | **—** | **(1325)** | **208000** |
| **Adjusted EBITDA** | **12414** | **3271** | **1622** | **(22352)** | **—** | **(5045)** |
| Share-based compensation expense | (800) | (141) | (411) | (1949) |  | (3301) |
| Restructuring costs<sup>(1)</sup> | (35) | (97) |  | (808) |  | (940) |
| New product launch issue<sup>(5)</sup> |  | (6888) |  |  |  | (6888) |
| Non-controlling interests |  |  | (70) |  |  | (70) |
| **EBITDA** | **11579** | **(3855)** | **1141** | **(25109)** | **—** | **(16244)** |
| Finance income and (expenses), net |  |  |  |  |  | (4284) |
| Depreciation and amortization |  |  |  |  |  | (12713) |
| **Loss before tax** |  |  |  |  |  | **(33241)** |

---

------

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Nine months ended September 30, 2025 <br>(in thousands of U.S. dollars)** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 349125 | 185167 | 94388 |  |  | 628680 |
| Intersegment revenue | 1274 |  |  |  | (1274) |  |
| **Total segment revenue** | **350399** | **185167** | **94388** | **—** | **(1274)** | **628680** |
| **Adjusted EBITDA** | **61673** | **(2510)** | **2568** | **(65909)** | **—** | **(4178)** |
| Share-based compensation expense | (1487) | (1004) | (1217) | (6417) |  | (10125) |
| Restructuring costs<sup>(1)</sup> | (710) | (1551) | (42) | (972) |  | (3275) |
| Strategic review of Greater China business<sup>(2)</sup> |  |  | (4911) |  |  | (4911) |
| Closure of production facility<sup>(3)</sup> | 846 |  |  |  |  | 846 |
| Non-controlling interests |  |  | (253) |  |  | (253) |
| **EBITDA** | **60322** | **(5065)** | **(3855)** | **(73298)** | **—** | **(21896)** |
| Finance income and (expenses), net |  |  |  |  |  | (70062) |
| Depreciation and amortization |  |  |  |  |  | (35735) |
| **Loss before tax** | **—** | **—** | **—** | **—** | **—** | **(127693)** |
| **Nine months ended September 30, 2024 <br>(in thousands of U.S. dollars)** | **Europe & International** | **North America** | **Greater China** | **Corporate\*** | **Eliminations\*\*** | **Total** |
| **Revenue** |  |  |  |  |  |  |
| Revenue from external customers | 325801 | 203859 | 79690 |  |  | 609350 |
| Intersegment revenue | 5103 |  |  |  | (5103) |  |
| **Total segment revenue** | **330904** | **203859** | **79690** | **—** | **(5103)** | **609350** |
| **Adjusted EBITDA** | **39548** | **4049** | **(2234)** | **(70609)** | **—** | **(29246)** |
| Share-based compensation expense | (1679) | 886 | (1590) | (7712) |  | (10095) |
| Restructuring costs<sup>(1)</sup> | (890) | (866) | (1940) | (879) |  | (4575) |
| Discontinued construction of production facilities<sup>(4)</sup> | (2923) | 1161 |  |  |  | (1762) |
| New product launch issue<sup>(5)</sup> |  | (12565) |  |  |  | (12565) |
| Non-controlling interests |  |  | (172) |  |  | (172) |
| **EBITDA** | **34056** | **(7335)** | **(5936)** | **(79200)** | **—** | **(58415)** |
| Finance income and (expenses), net |  |  |  |  |  | (11272) |
| Depreciation and amortization |  |  |  |  |  | (38034) |
| **Loss before tax** | **—** | **—** | **—** | **—** | **—** | **(107721)** |

---

\* Corporate consists of general costs not allocated to the segments.

\*\* Eliminations in 2025 and 2024 refer to intersegment revenue for sales of products from Europe & International to Greater China.

(1)Relates primarily to severance costs as the Group adjusts its organizational structure.

(2)Relates to costs related to the strategic review of the Greater China segment.

(3)Relates to reversal of previously recognized exit costs related to closure of the Group's production facility in Singapore.

(4)Relates primarily to non-cash impairments related to discontinued construction of the Group's production facility in Peterborough, UK, and reversal of previously recognized non-cash impairments related to discontinued construction of the Group's production facility in Dallas-Fort Worth, Texas.

(5)Expenses related to a new product launch issue.

**Europe & International**

Europe & International revenue increased $13.4 million, or 12.2%, to $123.3 million for the third quarter of 2025, compared to $109.9 million in the prior year period. Excluding a foreign currency exchange tailwind of $6.8 million, Europe & International revenue for the third quarter was $116.5 million, or an increase of 6.0%. For the third quarter of 2025, the volume growth was 8.4% primarily driven by growth in the Barista products. The revenue increase from volume growth for the third quarter was partially offset by a price/mix decline of 2.4%. Approximately 79% of Europe & International revenue was from the retail channel for the third quarter of 2025 compared to 82% in the prior year period. The sold finished goods volume for the three months ended September 30, 2025 and 2024 amounted to 83.6 and 77.2 million liters, respectively.

Europe & International Adjusted EBITDA increased $9.5 million to $21.9 million for the third quarter of 2025 compared to $12.4 million in the prior year period. The improvement in Adjusted EBITDA was primarily driven by higher gross profit driven by higher revenue and continued supply chain productivity.

------

**North America**

North America revenue decreased $7.0 million, or 10.1%, to $62.1 million for the third quarter of 2025, compared to $69.1 million in the prior year period. The sold finished goods volume for the three months ended September 30, 2025 and 2024 amounted to 34.4 million and 39.5 million liters, respectively. The 12.8% volume decrease was primarily due to reduction in sales to the segment's largest foodservice customer. Approximately 61% of North America revenue was from the retail channel in the third quarter of compared to 52% in the prior year period.

North America Adjusted EBITDA decreased $4.5 million to a loss of $1.3 million compared to a profit of $3.3 million in the prior year period. The reduction in Adjusted EBITDA was primarily due to lower gross profit, largely driven by lower sold volume and decreased fixed cost absorption.

**Greater China**

Greater China revenue increased $8.4 million, or 28.8%, to $37.4 million for the third quarter of 2025, compared to $29.1 million in the prior year period. The foreign currency exchange impact was minor for the quarter. The Greater China segment growth was primarily driven by increased sales across both the Foodservice and retail channels. Approximately 66% of Greater China revenue was from the foodservice channel for the third quarter of 2025 compared to 72% in the prior year period. The sold finished goods volume for the three months ended September 30, 2025 and 2024 amounted to 32.5 million and 24.6 million liters, respectively.

Greater China Adjusted EBITDA was stable versus prior year period at $1.6 million. The stability in EBITDA is explained by higher gross profit offset by higher selling, general and administrative expenses.

**Corporate**

Oatly's corporate expense, which consists of general costs not allocated to the segments, in the third quarter of 2025 was $21.4 million, a decrease of $3.8 million compared to the prior year period. Adjusted EBITDA in the third quarter of 2025 was a loss of $19.1 million compared to a loss of $22.4 million in the prior year period.

**Balance Sheet and Cash Flows**

As of September 30, 2025, the Company had cash and cash equivalents of $58.9 million and total outstanding debt of $507.7 million consisting of Convertible Notes and liabilities to credit institutions. Net cash used in operating activities was $17.4 million for the nine months ended September 30, 2025, compared to $104.2 million during the prior year period, which was primarily driven by improved operating results and improvements in net working capital.

As previously disclosed, on September 30, 2025, the Company issued Nordic Bonds with an initial issue amount of SEK 1,700 million and entered into a SEK 750 million super senior revolving credit facility. Following the satisfaction of certain conditions, the proceeds from the Nordic Bonds were released to the Company from escrow on October 3, 2025, and used to prepay the Term Loan B Credit Agreement in full, repurchase and cancel an aggregate amount of $42.9 million of its U.S. Convertible Notes and pay related transaction costs. Further, on October 3, 2025, the Company cancelled, terminated, and replaced its existing revolving credit facility with the new super senior revolving credit facility.

Capital expenditures were $13.8 million for the nine months ended September 30, 2025, compared to $28.9 million in the prior year period.

Free cash flow was an outflow of $31.1 million for the nine months ended September 30, 2025 compared to an outflow of $133.1 million during the prior year period. The improvement in free cash flow was driven by decreased net cash flows used in operating activities and lower capital expenditures.

*Free Cash Flow is a non-IFRS liquidity measure defined under "Non-IFRS financial measures." Please see "Reconciliation of IFRS to Non-IFRS Financial measures" at the end of this press release.*

**Strategic Review of Greater China Business**

The Company continues its strategic review of the Company's Greater China business announced last quarter.

There is no definitive timetable for completing the strategic review. The Company does not intend to provide further updates unless and until the Board of Directors has approved a specific course of action or determines that additional disclosure is appropriate or required. The Company cautions that there can be no assurances that the process will result in any transaction or strategic change.

------

**Outlook**

The Company's outlook continues to include the expected results of the Greater China segment. Based on the Company's assessment of the current operating environment and the actions it is taking, the Company is reaffirming its 2025 outlook for its primary metrics.

oConstant currency revenue growth is expected to be in the range of approximately flat to +1%;

oAdjusted EBITDA is expected to be in the range of positive $5 million to $15 million;

oCapital expenditures are expected to be approximately $20 million.

Based on recent foreign exchange rates, the full-year impact of foreign exchange is expected to be a tailwind to revenue growth by approximately 250 basis, compared to the prior expectation of a tailwind of approximately 150 basis points.

This outlook is provided in the context of significant macroeconomic uncertainty and other geopolitical uncertainties.

The Company cannot provide a reconciliation of constant currency revenue growth or Adjusted EBITDA guidance to the nearest comparable corresponding IFRS metric without unreasonable efforts due to difficulty in predicting certain items excluded from these non-IFRS measures. The items necessary to reconcile are not within Oatly's control, may vary greatly between periods and could significantly impact future financial results.

**Conference Call, Webcast and Supplemental Presentation Details**

Oatly will host a conference call and webcast at 8:00 a.m. ET today to discuss these results. The conference call, simultaneous, live webcast and supplemental presentation can be accessed on Oatly's Investors website at https://investors.oatly.com under "Events." The webcast will be archived for 30 days.

**About Oatly**

We are the world's original and largest oat drink company. For over 30 years, we have exclusively focused on developing expertise around oats: a global power crop with inherent properties. Our commitment to oats has resulted in core technical advancements that enabled us to unlock the breadth of the dairy portfolio, including alternatives to milks, ice cream, yogurt, cooking creams, spreads and on-the-go drinks. Headquartered in Malmö, Sweden, the Oatly brand is available in more than 50 countries globally.

For more information, please visit www.oatly.com.

**Forward-Looking Statements**

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding our financial outlook for 2025, profitability improvement, profitable growth in 2025, long-term growth strategy, expected capital expenditures, anticipated returns on our investments, anticipated supply chain performance, anticipated impact of our improvement plans, anticipated impact of our decision to discontinue construction of certain production facilities, plans to achieve profitable growth and anticipated cost savings and efficiencies as well as statements that include the words "expect", "intend", "plan", "believe", "project", "forecast", "estimate", "may", "should", "anticipate", "will", "aim", "potential", "continue", "is/are likely to" and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: our history of losses and how we may be unable to achieve or sustain profitability, including due to elevated inflation and increased costs for transportation, energy and materials; how our future business, financial condition and results of operations may be adversely affected by reduced or limited availability of oats and other raw materials and ingredients, which meet our quality standards, that our limited number of suppliers are able to sell us; how a failure to obtain necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing and development and other operations; those concerning our cash and cash equivalents maintained at financial institutions, often in balances that exceed federally insured limits; any damage or disruption at our production facilities, which manufacture the primary components of all our products; harm to our brand or reputation due to real or perceived quality, food safety, nutrition or sustainability issues with our products, which could have an adverse effect on our business, reputation, financial condition and results of operations; food safety and food-borne illness incidents or other safety concerns that have led to product recalls and how such events may in the future materially adversely affect our business, financial condition and results of operations by exposing us to lawsuits or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings; how a failure by our suppliers of raw

------

materials or co-manufacturers to comply with food safety, environmental or other laws and regulations, or with the specifications and requirements of our products, may disrupt our supply of products and adversely affect our business; we may not be able to compete successfully in our highly competitive markets; risks from consolidation of customers or the loss of a significant customer; a reduction in sales of our oatmilk varieties, which contribute a significant portion of our revenue, would have an adverse effect on our business, financial condition and results of operations; relying heavily on our co-manufacturing partners; our strategic partnerships with co-manufacturers may not be successful, which could adversely affect our operations and manufacturing strategy; failure by our logistics providers to deliver our products on time, or at all, could result in lost sales; that we may not successfully ramp up operations at any of our facilities, or these facilities may not operate in accordance with our expectations; a failure to effectively expand our processing, manufacturing and production capacity through existing facilities, or a failure to find acceptable co-manufacturing or co-manufacturing partners to help us expand, as we continue to grow and scale our business to a steady operating level; failure to develop and maintain our brand; failure to develop or introduce new products or successfully improve existing products may adversely affect our ability to continue to grow; a failure to cost-effectively acquire new customers and consumers or retain our existing customers and consumers, or a failure to derive revenue from our existing customers consistent with our historical performance; consumer preferences for our products are difficult to predict and may change, and, if we are unable to respond quickly to new trends, our business may be adversely affected; a failure to manage our future growth effectively; impairment charges for long-lived assets and other exit costs in connection with our production facilities, and how we may need to recognize further costs in the future; sustainability risks (including environmental, climate change, uncertainty about future related mandatory disclosure requirements, and broader corporate social responsibility matters), which may materially adversely affect our business as a result of lawsuits, regulatory investigations and enforcement actions, complaints concerning our disclosures, impacts on our operations and supply chain (particularly in connection with the physical impacts of climate change), and impacts on our brand and reputation; reliance on information technology systems and how any inadequacy, failure or interruption of, or cybersecurity incidents affecting, those systems may harm our reputation and ability to effectively operate our business; how cybersecurity incidents or other technology disruptions could negatively impact our business and our relationships with customers; risks associated with how our customers generally are not obligated to continue purchasing products from us; difficulties as we expand our operations into countries in which we have no prior operating experience; risks associated with the international nature of our business; the successful execution of the strategic review of the Company's Greater China operations, the outcome of the strategic review and the market reaction thereto; how our operations in China could expose us to substantial business, regulatory, political, financial and economic risks; our strategic reset in Asia may not be successful; if we fail to comply with trade compliance and economic sanctions laws and regulations of the United States, the EU and other applicable international jurisdictions, it could materially adversely affect our reputation and results of operations; packaging costs are volatile and may rise significantly; how fluctuations in our results of operations may impact, and may have a disproportionate effect on, our overall financial condition and results of operations; how litigation or legal proceedings could expose us to significant liabilities or costs and have a negative impact on our reputation or business; our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at similar rates, if at all; failure to retain our senior management or to attract, train and retain qualified employees; if we cannot maintain our company culture or focus on our mission as we grow, our success and our business and competitive position may be harmed; our insurance may not provide adequate levels of coverage against claims or we may be unable to find insurance with sufficient coverage at a reasonable cost; disruptions in the worldwide economy; macroeconomic conditions, including rising inflation, interest rates and supply chain constraints; global conflicts, other effects of ongoing wars and conflicts, and increasing geopolitical tensions and changes to international trade policies, treaties and tariffs, including as a result of the emergence of a trade war; the risk that legal claims, government investigations or other regulatory enforcement actions could subject us to civil and criminal penalties; how our operations are subject to U.S., EU, China and other laws and regulations, and there is no assurance that we will be in compliance with all regulations; changes in existing laws or regulations, or the adoption of new laws or regulations, may increase our costs and otherwise adversely affect our business, financial condition and results of operations; how we are subject to stringent environmental regulation and potentially subject to environmental litigation, proceedings and investigations; failure to protect our intellectual property, enforce or defend our intellectual property and other proprietary rights adequately, which may impact our commercial success; if we are unable to remediate material weaknesses, or if other material weaknesses are identified, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner; how our largest shareholder has significant influence over us, including significant influence over decisions that require the approval of shareholders; and the other important factors discussed under the caption "Risk Factors" in our Annual Report on Form 20-F for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission ("SEC") on March 13, 2025 and our other filings with the SEC as such factors may be updated from time to time. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Oatly disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

------

**Non-IFRS Financial Measures**

We use EBITDA, Adjusted EBITDA, Constant Currency Revenue as non-IFRS financial measures in assessing our operating performance and Free Cash Flow as a non-IFRS liquidity measure, and each in our financial communications.

"EBITDA" is defined as loss for the period adjusted to exclude, when applicable, income tax expense, finance expenses, finance income and depreciation and amortization expense.

"Adjusted EBITDA" is defined as loss for the period adjusted to exclude, when applicable, income tax expense, finance expenses, finance income, depreciation and amortization expense, share-based compensation expense, restructuring costs, costs related to the strategic review of the Greater China business, impacts related to the closure of production facility, discontinued construction of production facilities, expenses related to a new product launch issue and non-controlling interests.

Adjusted EBITDA should not be considered as an alternative to loss for the period or any other measure of financial performance calculated and presented in accordance with IFRS. There are a number of limitations related to the use of Adjusted EBITDA rather than loss for the period, which is the most directly comparable IFRS measure. Some of these limitations are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA excludes depreciation and amortization expense and, although these are non-cash expenses, the assets being depreciated may have to be replaced in the future increasing our cash requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect interest expense, or the cash required to service our debt, which reduces cash available to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect income tax payments that reduce cash available to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect recurring share-based compensation expense and, therefore, does not include all of our compensation costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect restructuring costs that reduce cash available to us in future periods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect costs related to the strategic review of the Greater China business that reduce cash available to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA excludes impacts related to the closure of production facility, although some of these may reduce cash available to us in future periods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA excludes impacts related to discontinued construction of production facilities, although some of these may reduce cash available to us in future periods;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Adjusted EBITDA does not reflect expenses related to a new product launch issue that reduced cash available to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•Other companies, including companies in our industry, may calculate Adjusted EBITDA differently, which reduces its usefulness as a comparative measure.

Adjusted EBITDA should not be considered in isolation or as a substitute for financial information provided in accordance with IFRS. Below we have provided a reconciliation of EBITDA and Adjusted EBITDA to loss for the period, the most directly comparable financial measure calculated and presented in accordance with IFRS, for the periods presented.

"Constant Currency Revenue" is calculated by translating the current year reported revenue amounts into comparable amounts using the prior year reporting period's average foreign exchange rates which have been provided by a third party. Constant Currency Revenue is a non-IFRS measure and is not a substitute for IFRS measures in assessing our overall financial performance.

Constant currency revenue is used to provide a framework in assessing how our business and geographic segments performed excluding the effects of foreign currency exchange rate fluctuations and we believe this information is useful to investors to facilitate comparisons and better identify trends in our business. Above we have provided a reconciliation of revenue as reported to revenue on a constant currency basis for the periods presented.

"Free Cash Flow" is defined as net cash flows used in operating activities less capital expenditures. We believe Free Cash Flow is a useful supplemental financial measure for us and investors in assessing our ability to pursue business opportunities and investments. Free Cash Flow is not a measure of our liquidity under IFRS and should not be considered as an alternative to net cash flows used in operating activities.

------

Free Cash Flow is a non-IFRS measure and is not a substitute for IFRS measures in assessing our overall financial liquidity. Because Free Cash Flow is not a measurement determined in accordance with IFRS, and is susceptible to varying calculations, it may not be comparable to other similarly titled measures presented by other companies. Free Cash Flow should not be considered in isolation, or as a substitute for an analysis of our results as reported on our interim condensed consolidated financial statements appearing elsewhere in this document. Below we have provided a reconciliation of Free Cash Flow to net cash flows used in operating activities for the periods presented.

**Contacts**

Oatly Group AB

+1 866-704-0391

investors@oatly.com

press.us@oatly.com

------

**Financial Statements**

**Interim condensed consolidated statement of operations**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
| **<br>(in thousands of U.S. dollars, except share and per share and ADS data)** | **2025** | **2024** | **2025** | **2024** |
| Revenue | 222796 | 208000 | 628680 | 609350 |
| Cost of goods sold | (156449) | (145979) | (432378) | (434475) |
| **Gross profit** | **66347** | **62021** | **196302** | **174875** |
| Research and development expenses | (4524) | (10867) | (13520) | (26407) |
| Selling, general and administrative expenses | (75146) | (79743) | (236755) | (242746) |
| Other operating income and (expenses), net | (3601) | (368) | (3658) | (2171) |
| **Operating loss** | **(16924)** | **(28957)** | **(57631)** | **(96449)** |
| Finance income and (expenses), net | (47557) | (4284) | (70062) | (11272) |
| **Loss before tax** | **(64481)** | **(33241)** | **(127693)** | **(107721)** |
| Income tax expense | (923) | (1389) | (6188) | (3194) |
| **Loss for the period** | **(65404)** | **(34630)** | **(133881)** | **(110915)** |
| Attributable to: |  |  |  |  |
| Shareholders of the parent | (65287) | (34560) | (133628) | (110743) |
| Non-controlling interests | (117) | (70) | (253) | (172) |
| **Loss per share, attributable to shareholders of the parent:** |  |  |  |  |
| Basic and diluted | (0.11) | (0.06) | (0.22) | (0.19) |
| **Loss per ADS, attributable to shareholder of the parent <br>(1 ADS representing 20 ordinary shares):** |  |  |  |  |
| Basic and diluted | (2.15) | (1.16) | (4.44) | (3.71) |
| **Weighted average common shares outstanding:** |  |  |  |  |
| Basic and diluted | 606332281 | 597968449 | 602057593 | 596434390 |

---

------

**Interim condensed consolidated statement of financial position**

---

| | | |
|:---|:---|:---|
| **(Unaudited)** | **September 30, 2025** | **December 31, 2024** |
| **(in thousands of U.S. dollars)** |  |  |
| **ASSETS** |  |  |
| **Non-current assets** |  |  |
| Intangible assets | 134432 | 116208 |
| Property, plant and equipment | 298939 | 294199 |
| Right-of-use assets | 41124 | 45555 |
| Other non-current receivables | 42138 | 44331 |
| Deferred tax assets | 4562 | 4561 |
| **Total non-current assets** | **521195** | **504854** |
| **Current assets** |  |  |
| Inventories | 63810 | 65602 |
| Trade receivables | 95717 | 103366 |
| Current tax assets | 5334 | 6095 |
| Other current receivables | 20410 | 15738 |
| Prepaid expenses | 14260 | 9402 |
| Cash and cash equivalents | 58903 | 98923 |
| **Total current assets** | **258434** | **299126** |
| **TOTAL ASSETS** | **779629** | **803980** |
| **EQUITY AND LIABILITIES** |  |  |
| **Equity** |  |  |
| Share capital | 107 | 106 |
| Treasury shares | (0) | (0) |
| Other contributed capital | 1628156 | 1628045 |
| Other reserves | (236768) | (274160) |
| Accumulated deficit | (1372806) | (1249303) |
| **Equity attributable to shareholders of the parent** | **18689** | **104688** |
| Non-controlling interests | 1195 | 1435 |
| **Total equity** | **19884** | **106123** |
| **Liabilities** |  |  |
| **Non-current liabilities** |  |  |
| Lease liabilities | 27033 | 31724 |
| Liabilities to credit institutions | 116312 | 116216 |
| Provisions | 5962 | 14857 |
| **Total non-current liabilities** | **149307** | **162797** |
| **Current liabilities** |  |  |
| Lease liabilities | 12862 | 13359 |
| Convertible Notes | 386783 | 324395 |
| Liabilities to credit institutions | 4586 | 5757 |
| Trade payables | 70862 | 60152 |
| Current tax liabilities | 730 | 1476 |
| Other current liabilities | 8262 | 7998 |
| Accrued expenses | 109332 | 103719 |
| Provisions | 17021 | 18204 |
| **Total current liabilities** | **610438** | **535060** |
| **Total liabilities** | **759745** | **697857** |
| **TOTAL EQUITY AND LIABILITIES** | **779629** | **803980** |

---

------

**Interim condensed consolidated statement of cash flows**

---

| | | |
|:---|:---|:---|
| **(Unaudited)** | **Nine months ended September 30,** | **Nine months ended September 30,** |
| **(in thousands of U.S. dollars)** | **2025** | **2024** |
| **Operating activities** |  |  |
| Net loss | (133881) | (110915) |
| Adjustments to reconcile net loss to net cash flows |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;—Depreciation of property, plant and equipment and right-of-use assets and amortization of intangible assets | 35735 | 38034 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Write-downs of inventories | 5705 | 1558 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Impairment (gain)/loss on trade receivables | (21) | 94 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Share-based compensation | 10125 | 10095 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Movements in provisions | (11902) | (37520) |
| &nbsp;&nbsp;&nbsp;&nbsp;—Finance (income) and expenses, net | 70062 | 11272 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Income tax expense | 6188 | 3194 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Impairment reversal related to discontinued construction of production facilities |  | 1747 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Other | (187) | 1307 |
| Interest received | 1226 | 6791 |
| Interest paid | (17807) | (18767) |
| Income tax paid | (2348) | (5325) |
| Changes in working capital: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;—Increase in inventories | (1) | (15110) |
| &nbsp;&nbsp;&nbsp;&nbsp;—Decrease in trade receivables, other current receivables, prepaid expenses | 10740 | 23164 |
| &nbsp;&nbsp;&nbsp;&nbsp;—Increase/(decrease) in trade payables, other current liabilities, accrued expenses | 9007 | (13811) |
| **Net cash flows used in operating activities** | **(17359)** | **(104192)** |
| **Investing activities** |  |  |
| Purchase of intangible assets | (1707) | (1439) |
| Purchase of property, plant and equipment | (12068) | (27483) |
| Proceeds from sale of property, plant and equipment | 374 | 24405 |
| Other | 415 | 774 |
| **Net cash flows used in investing activities** | **(12986)** | **(3743)** |
| **Financing activities** |  |  |
| Repayment of liabilities to credit institutions | (2006) | (2012) |
| Payment of loan transaction costs | (1020) | (4965) |
| Repayment of lease liabilities | (9369) | (17246) |
| Proceeds from exercise of warrants | 111 |  |
| **Cash flows used in financing activities** | **(12284)** | **(24223)** |
| **Net decrease in cash and cash equivalents** | **(42629)** | **(132158)** |
| Cash and cash equivalents at the beginning of the period | 98923 | 249299 |
| Exchange rate differences in cash and cash equivalents | 2609 | 2192 |
| **Cash and cash equivalents at the end of the period** | **58903** | **119333** |

---

------

**Reconciliation of IFRS to Non-IFRS Financial measures**

***Reconciliation of EBITDA and Adjusted EBITDA to loss for the period***

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
| **(in thousands of U.S. dollars)** | **2025** | **2024** | **2025** | **2024** |
| Loss for the period | (65404) | (34630) | (133881) | (110915) |
| Income tax expense | 923 | 1389 | 6188 | 3194 |
| Finance (income) and expenses, net | 47557 | 4284 | 70062 | 11272 |
| Depreciation and amortization expense | 12260 | 12713 | 35735 | 38034 |
| **EBITDA** | **(4664)** | **(16244)** | **(21896)** | **(58415)** |
| Share-based compensation expense | 3080 | 3301 | 10125 | 10095 |
| Restructuring costs<sup>(1)</sup> | 1050 | 940 | 3275 | 4575 |
| Strategic review of Greater China business<sup>(2)</sup> | 3533 |  | 4911 |  |
| Closure of production facility<sup>(3)</sup> |  |  | (846) |  |
| Discontinued construction of production facilities<sup>(4)</sup> |  |  |  | 1762 |
| New product launch issue<sup>(5)</sup> |  | 6888 |  | 12565 |
| Non-controlling interests | 117 | 70 | 253 | 172 |
| **Adjusted EBITDA** | **3116** | **(5045)** | **(4178)** | **(29246)** |

---

(1)Relates primarily to severance costs as the Group adjusts its organizational structure.

(2)Relates to costs related to the strategic review of the Greater China segment.

(3)Relates to reversal of previously recognized exit costs related to closure of the Group's production facility in Singapore.

(4)Relates primarily to non-cash impairments related to discontinued construction of the Group's production facility in Peterborough, UK, and reversal of previously recognized non-cash impairments related to discontinued construction of the Group's production facility in Dallas-Fort Worth, Texas.

(5)Expenses related to a new product launch issue.

***Reconciliation of Free Cash Flow to Net Cash Flows used in Operating Activities*** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(Unaudited)** | **Three months ended September 30,** | **Three months ended September 30,** | **Nine months ended September 30,** | **Nine months ended September 30,** |
| **(in thousands of U.S. dollars)** | **2025** | **2024** | **2025** | **2024** |
| Net cash flows used in operating activities | (2354) | (18179) | (17359) | (104192) |
| Capital expenditures | (3076) | (8502) | (13775) | (28922) |
| **Free Cash Flow** | **(5430)** | **(26681)** | **(31134)** | **(133114)** |

---

------